Norris Medicines Ltd — Important, 03-07-2026: Company Update

Norris Medicines Limited has submitted a routine compliance certificate from its Registrar and Transfer Agent for the quarter ended June 30, 2026. This certificate confirms that all physical shares received for dematerialization were successfully converted into electronic form. The process included confirming to depositories, ensuring the shares are listed, and cancelling physical certificates. This ensures accurate shareholder records and maintains market liquidity for investors by streamlining the conversion of shares.